Skip to main content
Sign In

Who We Are

Clinicians and Clinical Researchers
Clinical Research Coordinators
Brain Bank
Laboratory Researchers, Faculty, Staff, and Students



Huntington Potter, PhD
Director, Rocky Mountain Alzheimer's Disease Center
Dr. Huntington Potter is Professor of Neurology and the Linda Crnic Center for Down Syndrome, and is Director of the Rocky Mountain Alzheimer's Disease Center at the University of Colorado Anschutz Medical Center. Previously, Dr. Potter studied, researched and taught for 30 years at Harvard University. He then designed and directed the Florida Alzheimer's Disease Research Center and the Johnnie B. Byrd Sr. Alzheimer's Center & Research Institute. He is currently expanding his discovery that Alzheimer's disease is mechanistically related to Down syndrome, which invariably leads to Alzheimer's by age 30-40, through the development of many cells with trisomy 21 and other aneuploidy. Recently, he and his colleagues have found such cell cycle defects in numerous other neurodegenerative diseases, providing a novel approach to diagnosis and therapy. They are also developing several new treatments for Alzheimer's disease for testing first in animals and soon in humans. One, Leukine, is currently in clinical trials. Dr. Potter is author of over 100 scientific articles, books and patents, has received numerous awards for his work, and is a Fellow of the American Association for the Advancement of Science and the National Academy of Inventors. His electron micrographs of DNA are on permanent exhibit in the National American History Museum of the Smithsonian Institute in Washington D.C.

Jonathan H Woodcock, MD
Co-Director RMADC Clinical Core
Jonathan Woodcock, MD, serves as Assistant Professor of Neurology and Psychiatry, Clinical Director of the University of Colorado Hospital’s Memory Disorders Clinic, and Clinical Director of the Rocky Mountain Alzheimer’s Disease Center. Dr. Woodcock directs clinical research projects in dementia including medication trials in Alzheimer’s disease, cognitive and functional deficits in adults with Down syndrome, and assessment and management of behavioral syndromes in dementia. He is involved with the development of a brain tissue repository for RMADC. Before assuming his role at the University of Colorado, Dr. Woodcock held several academic appointments, including teaching assignments at Case Western Reserve and Harvard University, as well as many years on the clinical faculty of the Behavioral Neurology Section of the Department of Neurology of the University of Colorado. He also established several hospital neuropsychiatric and behavioral rehabilitation programs, and ran private practices in Boston and Colorado focusing on outpatient care in neurology, neuropsychiatry, and neurobehavioral rehabilitation. He often calls the human brain “the most complex thing we know of in the universe.”

Brianne Bettcher, PhD
Director, Neuropsychology Research
Co-Director, RMADC Clinical Core

Dr. Bettcher is an Assistant Professor and neuropsychologist in the Departments of Neurology and Neurosurgery. She obtained a PhD from Temple University in Clinical Psychology with a specialization in Neuroscience, and she completed her fellowship at the University of California San Francisco’s Memory and Aging Center. She sees patients clinically at the Memory Disorders Clinic, and specializes in early age of onset and atypical presentations of Alzheimer's disease. Dr. Bettcher’s research laboratory is focused on the neurobiology of aging, and seeks to understand the role of immune system dysfunction in aging and Alzheimer’s disease. Dr. Bettcher uses neuroimaging, cognitive testing, blood markers, and molecular imaging in her research studies to better understand what puts people at risk for Alzheimer’s disease and what protects aging adults from developing Alzheimer’s disease.

Meet Dr. Bettcher

Clinicians and Clinical Researchers


Peter S Pressman, MD
Director, RMADC outreach
Peter S. Pressman, MD is an Assistant Professor in Cognitive and Behavioral Neurology at the University of Colorado, where he is involved with clinical trials at the Rocky Mountain Alzheimer’s Disease Center and sees patients in the Memory Disorders Clinic. Dr. Pressman obtained his MD from Oregon Health & Science University, did his residency at Chicago’s Northwestern Memorial Hospital, and completed a fellowship at the Memory and Aging Center of the University of California, San Francisco. Dr. Pressman specializes in frontotemporal dementias and primary progressive aphasias, and is particularly interested in verbal and nonverbal communication deficits in neurodegenerative disease.

Meet Dr. Pressman​



Christopher M. Filley, MD
Christopher M. Filley, MD, is Director of the Behavioral Neurology Section, and Professor of Neurology and Psychiatry, at the University of Colorado School of Medicine. Dr. Filley evaluates patients referred for behavioral neurology consultation at the Neurobehavior Clinic of the University of Colorado Hospital, providing a regional resource for expert subspecialty opinion regarding complex disorders of cognition. Although Alzheimer's Disease has been a major focus of his work, his primary interest is in the behavioral neurology of white matter, including neurologic, psychiatric, neuropsychological, neuroimaging, and neuropathological aspects of a wide variety of white matter disorders. Through his role in the RMADC Clinical Core, Dr. Filley is a Research Physician on the current Leukine® clinical safety trial, and he will continue to participate in clinical trials for potential Alzheimer’s disease and other dementia therapeutics. He is also the author of three monographs – Neurobehavioral Anatomy, The Behavioral Neurology of White Matter, and White Matter Dementia – and he is the senior editor of the textbook Behavioral Neurology & Neuropsychiatry.
Holden 2017.JPG

Samantha Holden, MD
Director, Memory Disorders Clinic

Samantha Holden, MD, is an Assistant Professor in the Department of Neurology at the University of Colorado Anschutz Medical Center. She currently practices in the Memory Disorders Clinic at University of Colorado Hospital. Dr. Holden received her BS in Neural Science from New York University and her MD from Stony Brook University School of Medicine. She completed her medical internship and neurology residency at Rush University Medical Center in Chicago, IL. With training in both behavioral neurology and movement disorders, Dr. Holden’s research focuses on cognition, behavior and quality of life in parkinsonian conditions. Her current research projects include determining the best methods for predicting and diagnosing dementia in Parkinson’s disease, as well as investigating non-pharmacological treatments for bothersome behavioral symptoms in dementia, such as music therapy. She is interested in developing practical and personally meaningful interventions to improve quality of life for people living with neurodegenerative dementias.​

Brice McConnell, MD, PhD
Director, Sleep Research Program
Brice McConnell, MD, PhD is an Assistant Professor of Neurology at the University of Colorado Anschutz Medical Center, where he is involved with clinical trials at the CU Alzheimer's and Cognition Center and sees patients in the Memory Disorders Clinic. Dr. McConnell earned his medical doctorate at University of Colorado School of Medicine. In addition, he completed graduate school and earned his PhD in Molecular Biology at the University of Colorado Anschutz Medical Campus. His current research focuses on identifying and enhancing the restorative and neuroprotective aspects of sleep that are lost with aging and neurodegenerative disease. He is currently leading a study that is utilizing at-home electroencephalography (measurement and recording of electrical activity in the brain) to characterize neuroprotective brain communication events during sleep as early biomarkers of neurodegenerative disease. Additionally, he is leading a study that seeks to enhance these beneficial sleep functions through the use of non-invasive brain stimulation as a potential treatment and/or preventative for Alzheimer's disease. Read more about these studies here.


Victoria S. Pelak, MD
Co-Director, RMADC Clinical Research

Victoria S. Pelak, MD, is a Professor of Neurology and Ophthalmology at the University of Colorado School of Medicine with subspecialty fellowship training in Neuro-ophthalmology and subspecialty certification in Behavioral Neurology and Neuropsychiatry. She specializes in assessing and treating patients with visual problems related to neurological diseases, and she has clinical expertise in vision symptoms related to Alzheimer’s disease, Posterior Cortical Atrophy, Parkinson's disease, and similar disorders. She built and founded the Brain and Vision Laboratory at the University of Colorado School of Medicine in order to study higher order visual perception, and she has a particular research interest in visual motion processing. She sees patients at the Rocky Mountain Lions Eye Institute at the University of Colorado Hospital outpatient pavilion located in Aurora, Colorado. Dr. Pelak completed her medical degree in her hometown of Detroit, Michigan, at Wayne State University School of Medicine and her residency in Neurology and fellowship training at the University of Pennsylvania.

Meet Dr. Pelak​

Justin Otis, MD






Justin Otis, MD, was born in Alberta, Canada and moved to Des Moines, Iowa in grade school. He attended Saint John's University in Minnesota and received a B.A. in Applied Physics and a minor in Mathematics, and moved on to research in Medical Physics at the University of Iowa prior to attending medical school at Creighton University. He completed a psychiatry residency at the University of Arizona, and is interested in delirium, neuroimmunology in cognitive and affective disorders, integrative medicine, and prevention.


Patrice McMoon, PC-A
Patrice McMoon, PA-C is a Physician Assistant in the Department of Neurology, in the Behavioral Neurology and Memory Disorders Clinic. Ms. McMoon earned her Masters of Physician Assistant Studies at James Madison University in Harrisonburg, VA. She is actively involved in the care of complex patients with various cognitive disorders secondary to neurologic disease and traumatic brain injury. She speaks Spanish and is interested in increasing access to care to both Spanish and English speaking patients. In addition, Ms. McMoon is a member of the research team for the Rocky Mountain Alzheimer’s Disease Center and assists with clinical assessment of research study subjects. Her other research interests include gain of function in traumatic brain injury and the use of language acquisition to preserve brain function in dementia.

Kelly Darrow, FNP-BC. RN


Kelly Darrow is a Board Certified Family Nurse Practitioner in the Department of Neurology. Ms. Darrow is an Advanced Practice provider in the Behavioral Neurology and Memory Disorders clinic. She received a B.A. from Colgate University and M.S. in Nursing from Vanderbilt University. Prior to coming to the Memory Disorders Clinic, Kelly has largely worked in family medicine, specifically in a community health center context, as well as a retail clinic setting. Her research interests include Alzheimer's Disease and related dementias, global health, health impacts of climate change. In her current role, she treats patients with neurological and memory disorders, including Alzheimer's Disease and other neurodegenerative diseases. ​ 

Clinical Research Coordinators


Katherine Varley, BS

Katherine Varley joined the team as a Clinical Research Coordinator in November 2016. She graduated from Regis University in 2015 with her bachelor’s degree in Neuroscience. During her time at Regis, she completed an internship studying the effects of forced exercise on methamphetamine-induced neurotoxicity in rats, to determine if exercise is a viable treatment option for both METH addiction and Parkinson’s Disease. Her love for Neuroscience and interest in memory disorders led her to the Neuroscience Department at CU.  Currently, she is lead coordinator on the EMERGE clinical trial, sponsored by Biogen Pharmaceuticals.  She also helps coordinate Dr. Potter’s clinical trial studying GM-CSF and Dr. Bettcher’s longitudinal observational study. Recently, she started a new role as an internal monitor for both Dr. Bettcher and Dr. Potter.

​Jada Boyd, BS​





Jada Boyd, BS joined the team as a Clinical Professional Research Assistant in April of 2018. She graduated from Colorado State University in Fort Collins Colorado in 2016 with a Bachelor of Science Degree in Biomedical Science. As an undergraduate, she was a research assistant for the Department of Radiation Cancer Biology and Oncology at CSU through the University of Colorado Cancer Research Summer Fellowship program. During her time as a research assistant, Jada focused on using yeast as a model for highly conserved mutations that lead to cancer in humans. Before moving to the Department of Neurology, she worked with the Division of Gastroenterology and Hepatology coordinating research involving Primary Sclerosing Cholangitis and Primary Biliary Cholangitis. She currently administers neuropsychological cognitive assessments for Dr. Brianne Bettcher’s Longitudinal Biomarker study and Dr. Huntington Potter’s GM-CSF clinical trials.​
​Rini Kaplan, BS​




Rini Kapan, MSc, joined the team as a Professional Research Assistant in October 2017. She graduated from the University of Colorado Boulder in 2012 with a BA in Integrative Physiology and Psychology and a concentration in Neuroscience. As an undergraduate, she volunteered as a research assistant investigating executive function and racial bias. Rini subsequently attended the University of Edinburgh where she graduated in 2014 with an MSc in Human Cognitive Neuropsychology. During her time at Edinburgh, she conducted research on the neuropsychological characterization of healthy controls and the comparison of performance in real and virtual reality environments. Rini is the coordinator for Dr. McConnell’s studies using transcranial electrical current stimulation and for Dr. Pelak’s optical coherence tomography study in pre-AD. She also assists with administering neuropsychological assessments for some of the other team’s studies and with data management. 
​Tanner Gustavsen, BS​







Tanner Gustavsen joined the team as a Professional Research Assistant in June 2018. He graduated from Carroll College in Helena, MT with a BA in Biochemistry and Molecular Biology. As an undergraduate, he was employed as a research assistant and examined the climatic and topographical factors influencing the distribution of D. andersoni throughout Western Montana. During this time, Tanner also volunteered for hospice, Big Brothers Big Sisters, and a number of other organizations. His passion for research and service have led him to clinical research. Tanner is the coordinator for Dr. Bettcher’s Longitudinal Biomarker and Clinical Phenotyping Study. He organizes and conducts regular study visits for insight into the causes and treatments for Alzhiemer’s Disease, Down Syndrome, and other neurocognitive disorders. 

​Michelle Stocker, BA​






Michelle Stocker joined the team as a Professional Research Assistant in September 2018. She graduated from Elon University in North Carolina in 2016 with a Bachelor of Arts degree in Psychology, and Neuroscience and Biology minors. Michelle’s research interests focus on memory and learning across the lifespan - while at Elon she produced an undergraduate honors thesis working in the Cognitive Neuroscience of Memory & Aging Lab. Her thesis focused on the Associative Deficit Hypothesis and the Item-Specific-Relational Framework, and how those theories could be combined to help older adults and college students find ways to improve their memory. Prior to joining the Department of Neurology, Michelle worked for the Institute for Behavioral Genetics at CU-Boulder as a PRA for the Adolescent Brain Cognitive Development Study, a nation-wide longitudinal study collecting a wide range of data on adolescent development. Currently, she is the lead coordinator for Dr. Huntington Potter’s GM-CSF clinical trials.


Communications and Community Outreach



Helen Gray, MBA
Helen Gray, BA, MBA, is Communications and Community Outreach Coordinator for RMADC. She joined RMADC as a Professional Research Assistant, after working as a caregiver and activities coordinator in assisted living. Helen volunteered at the Colorado chapter of the Alzheimer’s Association, working in fundraising, the speaker’s bureau, and the telephone helpline. Helen earned a BA at the University of Utah, an MBA at the University of Minnesota, and has studied additionally in Gerontology. In her previous career path, Helen was a Denver journalist, working in commercial and public television, corporate production, and at Colorado Public Radio where she was a news host. She draws from her communication background at RMADC, helping with media inquiries, community presentations, managing the RMADC website, the RMADC Facebook page, and interacting with patients.

Brain Bank


Bette K. Kleinschmidt-DeMasters, MD
Bette K. Kleinschmidt-DeMasters, MD, is a Professor of Pathology, is a board certified Neuropathologist, and Past-President of the American Association of Neuropathologists (2005). As a diagnostic pathologist for over 25 years, Dr. DeMasters has studied various degenerative brain diseases, which have resulted in over 230 peer-reviewed publications. Her work also involves radiation-induced tumors, neoplasms in patients of varying ages, and pediatric brain tumors. For the RMADC, Dr. DeMasters is involved in the RMADC Brain Donation Program. Dr. DeMasters received her MD from the University of Wisconsin and was a Neuropathology Fellow at the University of Kansas and the University of Colorado.

Ann-Charlotte (“Lotta”) Granholm, PhD, DDS
Ann-Charlotte (“Lotta”) Granholm, PhD, DDS, is the founding Executive Director of the Knoebel Center for the Study of Aging at the University of Denver. She is Founder and Chair of the ISTAART Professional Interest Area (PIA) on Down Syndrome and Alzheimer’s disease. Dr. Granholm is collaborating with members of the RMADC to further develop and expand the research program focused on Down syndrome and Alzheimer’s disease. She is helping to oversee the infrastructure of the Brain Donation Program at the RMADC.

Brian Moore, MD
Brian E. Moore, MD, MEd is an associate professor of pathology, board-certified neuropathologist, and vice chair of the neuropathology committee of the College of American Pathologists. In addition to his work in surgical neuropathology, Dr. Moore conducts brain autopsies at the University of Colorado Hospital investigating neurodegenerative diseases including Alzheimer's disease, Lewy Body Disease, and Frontotemporal Lobar Degeneration. After receiving a Master's degree in Education from Harvard University, Dr. Moore received his MD from the University of Massachusetts and was a Neuropathology Fellow at Brown University in Providence, Rhode Island. Before coming to the University of Colorado, Dr. Moore was an associate professor at Southern Illinois University and was Brain Bank Director for the SIU Center for Alzheimer's Disease and Related Disorders.


Laboratory Researchers, Faculty, Staff, and Students


Arockia Ranjitha Dhanasekaran, PhD
A Ranjitha Dhanasekaran, PhD, joined the Rocky Mountain Alzheimer’s Disease Center as Faculty Research Associate in January 2017 and is working with Dr. Huntington Potter. Dr. Dhanasekaran earned her Bachelor of Engineering in Computer Science & Engineering from the Univesity of Madras, India. In 2006, she earned her Master of Science in Computer Science with a specialization in Bioinformatics from Utah State University. In her Master's, she modeled and simulated the role of genetic regulatory networks in cellular pattern formation. She received her Doctorate in Computer Science with a specialization in Bioinformatics from Utah State University in 2011. She modeled and simulated dynamic state metabolic flux. She has been working at the Linda Crnic Institute for Down Syndrome at the University of Colorado Anschutz Medical Campus since 2012. Her research interests are Bioinformatics and Computational Biology using Artificial Intelligence and Machine Learning. She will be focusing on pattern formation, knowledge discovery in databases, combinatorial drugs and single cell genomics.

Athena Ching-Jung Wang, PhD
Athena Ching-Jung Wang joined the Crnic Institute in May 2013, and works in Dr. Huntington Potter’s lab. She received Master of Science in Biology in 2002 at New York University and proceeds to work at Rockefeller University in Dr. Bruce McEwen’s laboratory. She studied the impact of stress to the brain especially material separation stress and social stress. At 2005, she started at Mount Sinai school of medicine for her PhD study, where she studied the relationship between normal aging and estrogen in Dr. Morrison laboratory. Her thesis title “Is Estrogen a fountain of youth?” Which elusive the complicate behavior and molecular association during the menopause and how estrogen might protect in some case in normal aging female. She received her Ph.D. from the Mount Sinai School of Medicine at 2010. When she joined Dr. Potter at 2013, she focus on pathological of aging. Her focus turn to (1)“Alzheimer disease(AD), a type three diabetic “ .(2) Drug discover focus on ApoE4 risk factor for AD.(3)Down Syndrome link to AD and development of drug.

Christina Coughlan, PhD
Christina Coughlan is a Senior Faculty Research Instructor in the lab of Dr. Potter in the Department of Neurology at the University of Colorado Anschutz Medical Center. Dr. Coughlan’s research interests are focused on finding biomarkers for Alzheimer’s disease (AD) and screening drugs for their ability to inhibit the development and progression of AD. Dr. Coughlan received her BSc (Hons) in Pharmacology and Toxicology and her PhD in Pharmacology from University College Dublin, Ireland. As a postdoctoral fellow at Ninewells Hospital and Medical school in Scotland, Dr. Coughlan received an Alzheimer’s Disease Society of Great Britain fellowship, an award only granted to ten in the UK at that time. Previous to joining UC Denver, Dr. Coughlan did a postdoctoral fellowship at the University of Pennsylvania and was an Assistant Professor of Biology at the University of Denver.

Glenn Simon, PhD
Glenn Simon, PhD, joined the Crnic Institute in December of 2013, and works in Dr. Huntington Potter’s lab. He received his B.S. from the University of Delaware in 2003 and his Ph.D. from the University of Colorado Health Sciences Center in 2008. His primary research is focused on the function of the amyloid precursor protein and its typical function in the brain. He is also interested in the expression of different isoforms of the amyloid precursor protein in the human brain. Certain isoforms of amyloid precursor protein are primarily expressed in the brains of healthy individuals, the ratio of these isoforms shifts in brains from Alzheimer’s patients. Dr. Simon’s work on better understanding of how the amyloid precursor protein functions and why certain isoforms are expressed in neurons may hold clues to neurodegenerative disease progression or prevention.

Heidi Chial, PhD
Heidi Chial, PhD, is a Writing Specialist and Faculty Research Instructor in the Department of Neurology at the University of Colorado Anschutz Medical Center. Dr. Chial works with members of the Rocky Mountain Alzheimer’s Disease Center (RMADC), the Department of Neurology, and the Linda Crnic Institute for Down Syndrome to prepare grant applications and manuscripts for publication. She is also involved in the development and implementation of both basic science and clinical research projects. She received her PhD from the Dept. of Molecular, Cellular, and Developmental Biology at the University of Colorado at Boulder, and she completed postdoctoral research training at the Mayo Clinic, Wake Forest University School of Medicine, the Marine Biological Laboratory (MBL), and Stanford University School of Medicine. After meeting Dr. Potter and learning about his research program and their overlapping scientific interests in the connections between Alzheimer’s Disease, Down syndrome, and aneuploidy, Dr. Chial joined the RMADC in 2015.

Md Mahiuddin Ahmed, PhD
Md Mahiuddin Ahmed joined the Crnic Institute in July 2012, and works in Katheleen Gardiner’s lab until 2016. He joined in Dr. Potter’s lab and RMADC research group in 2017. He received his Ph.D. from Yokohama City University in Japan.

Stefan Sillau, PhD
Dr. Sillau is the Department of Neurology's biostatistician, and provides statistical support for clinical trials and research projects, including basic research and clinical outcomes and effectiveness: study design and data analysis.

Timothy Boyd, PhD, MSB
Timothy Boyd, PhD, MSB, is a Faculty Research Instructor in the laboratory of Dr. Huntington Potter within the Department of Neurology and the Linda Crnic Institute for Down Syndrome at the University of Colorado Anschutz School of Medicine. Dr. Boyd received a Master in Biotechnology and a PhD in Medical Sciences at the University of South Florida, researching the mechanisms that underlie the inverse relationship between Rheumatoid arthritis (RA) and Alzheimer’s disease (AD), in which the vast majority of individuals with RA do not tend to develop AD. His research identified a factor, increased in RA, that rapidly reversed AD pathology and cognitive impairment in models of AD, and found that the human version of this factor, commercially known as Leukine®/sargramostim , was also associated with improved cognition in cancer patients who acquire cognitive impairment from their chemotherapy treatments. This research has led to ongoing clinical trials of Leukine® within mild-to-moderate AD subjects at the University of Colorado Anschutz Medical Campus (NCT01409915) and in Mild Cognitive Impaired (MCI) subjects at Baylor Medical School in Houston, Texas (NCT02667496). Currently, he is working to help establish a state-of-the-art biorepository for the Rocky Mountain Alzheimer’s Disease Center, to study biomarkers from blood samples of adults with Down Syndrome, MCI, AD, and normal aging subjects at the University of Colorado Hospital Memory Disorder Clinic, and to investigate mechanisms of Traumatic Brain Injury (TBI) that cause it to be a risk factor for AD and Chronic Traumatic Encephalopathy. Additionally, Dr. Boyd is an investigator on a Cerebral Palsy Adult Transition Longitudinal Study (NCT02137005) to study blood biomarkers from samples of subjects with Cerebral Palsy at Children’s Hospital Colorado.


Noah Johnson, PhD
Noah Johnson, PhD, joined the Rocky Mountain Alzheimer’s Disease Center in August 2018 as a postdoctoral scholar, working with Dr. Huntington Potter to explore the pathogenic mechanisms of Alzheimer’s and other dementing diseases. Noah received his PhD in Biomedical Engineering from the University of Pittsburgh where he developed protein delivery systems for regenerative medicine and tissue engineering. Most recently, he completed a postdoctoral appointment at UCSF with Stan Prusiner, where he studied the prion-like properties of proteins causing neurodegenerative diseases. His research at the RMADC will focus on uncovering new mechanisms of protein misfolding and aggregation using novel cell and animal models of Alzheimer’s disease​

Mihret Elos, MS
Mihret Elos joined the Crnic Institute in September 2016, and works in Dr. Huntington Potter’s lab. She received her master’s degree from the University of Colorado Anschutz Medical Campus.

Neil Markham, MBA
Neil Markham joined the Crnic Institute in January 2012. He received his bachelor’s degree from the University of Colorado Denver.

Esteban Lucero, BS
Esteban Lucero is a current graduate student in the Department of Neurology at Anschutz Medical Campus. He joined the Crnic Institute in August 2014, and works in Dr. Huntington Potter’s lab. He received his bachelor’s degree in Biology from New Mexico State University.

Vanesa Adame, BS
Vanesa Adame joined the Crnic Institute in August 2015, and works in Dr. Huntington Potter’s lab as a Professional Research Assistant. She received her bachelor’s degree in Biology from the University of New Mexico. Vanesa is currently involved in processing subject blood samples for the Longitudinal Biomarker Study and Leukine® trial. Additionally, she is investigating folic acid as a possible treatment for chromosomal abnormalities.